vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Hillman Solutions Corp. (HLMN). Click either name above to swap in a different company.

Hillman Solutions Corp. is the larger business by last-quarter revenue ($370.1M vs $270.8M, roughly 1.4× HUTCHMED (China) Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -1.3%, a 2.0% gap on every dollar of revenue. On growth, Hillman Solutions Corp. posted the faster year-over-year revenue change (3.0% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-34.3M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Hillman Solutions is an American hardware manufacturing, distribution and consumer fabrication services company.

HCM vs HLMN — Head-to-Head

Bigger by revenue
HLMN
HLMN
1.4× larger
HLMN
$370.1M
$270.8M
HCM
Growing faster (revenue YoY)
HLMN
HLMN
+19.5% gap
HLMN
3.0%
-16.5%
HCM
Higher net margin
HCM
HCM
2.0% more per $
HCM
0.7%
-1.3%
HLMN
More free cash flow
HCM
HCM
$37.7M more FCF
HCM
$3.4M
$-34.3M
HLMN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HCM
HCM
HLMN
HLMN
Revenue
$270.8M
$370.1M
Net Profit
$2.0M
$-4.7M
Gross Margin
37.7%
Operating Margin
-13.2%
1.9%
Net Margin
0.7%
-1.3%
Revenue YoY
-16.5%
3.0%
Net Profit YoY
-83.6%
EPS (diluted)
$0.00
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
HLMN
HLMN
Q1 26
$370.1M
Q4 25
$270.8M
$365.1M
Q3 25
$424.9M
Q2 25
$277.7M
$402.8M
Q1 25
$324.5M
$359.3M
Q4 24
$349.6M
Q3 24
$393.3M
Q2 24
$305.7M
$379.4M
Net Profit
HCM
HCM
HLMN
HLMN
Q1 26
$-4.7M
Q4 25
$2.0M
$1.6M
Q3 25
$23.2M
Q2 25
$455.0M
$15.8M
Q1 25
$11.9M
$-317.0K
Q4 24
$-1.2M
Q3 24
$7.4M
Q2 24
$25.8M
$12.5M
Gross Margin
HCM
HCM
HLMN
HLMN
Q1 26
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Operating Margin
HCM
HCM
HLMN
HLMN
Q1 26
1.9%
Q4 25
-13.2%
4.6%
Q3 25
10.8%
Q2 25
-1.3%
9.0%
Q1 25
-5.0%
4.2%
Q4 24
4.0%
Q3 24
6.8%
Q2 24
-9.0%
8.3%
Net Margin
HCM
HCM
HLMN
HLMN
Q1 26
-1.3%
Q4 25
0.7%
0.4%
Q3 25
5.5%
Q2 25
163.8%
3.9%
Q1 25
3.7%
-0.1%
Q4 24
-0.3%
Q3 24
1.9%
Q2 24
8.4%
3.3%
EPS (diluted)
HCM
HCM
HLMN
HLMN
Q1 26
$-0.02
Q4 25
$0.00
$0.00
Q3 25
$0.12
Q2 25
$0.52
$0.08
Q1 25
$0.01
$0.00
Q4 24
$-0.00
Q3 24
$0.04
Q2 24
$0.03
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
HLMN
HLMN
Cash + ST InvestmentsLiquidity on hand
$1.4B
$27.7M
Total DebtLower is stronger
$93.2M
$714.1M
Stockholders' EquityBook value
$1.2B
$1.2B
Total Assets
$1.8B
$2.4B
Debt / EquityLower = less leverage
0.08×
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
HLMN
HLMN
Q1 26
$27.7M
Q4 25
$1.4B
$27.3M
Q3 25
$37.7M
Q2 25
$1.4B
$34.2M
Q1 25
$836.1M
$36.3M
Q4 24
$44.5M
Q3 24
$59.8M
Q2 24
$802.5M
$54.0M
Total Debt
HCM
HCM
HLMN
HLMN
Q1 26
$714.1M
Q4 25
$93.2M
$668.3M
Q3 25
$683.2M
Q2 25
$93.4M
$683.1M
Q1 25
$82.8M
$713.5M
Q4 24
$691.7M
Q3 24
$730.7M
Q2 24
$82.1M
$732.1M
Stockholders' Equity
HCM
HCM
HLMN
HLMN
Q1 26
$1.2B
Q4 25
$1.2B
$1.2B
Q3 25
$1.2B
Q2 25
$1.2B
$1.2B
Q1 25
$759.9M
$1.2B
Q4 24
$1.2B
Q3 24
$1.2B
Q2 24
$740.1M
$1.2B
Total Assets
HCM
HCM
HLMN
HLMN
Q1 26
$2.4B
Q4 25
$1.8B
$2.4B
Q3 25
$2.4B
Q2 25
$1.8B
$2.4B
Q1 25
$1.3B
$2.3B
Q4 24
$2.3B
Q3 24
$2.4B
Q2 24
$1.3B
$2.4B
Debt / Equity
HCM
HCM
HLMN
HLMN
Q1 26
0.59×
Q4 25
0.08×
0.54×
Q3 25
0.56×
Q2 25
0.08×
0.57×
Q1 25
0.11×
0.60×
Q4 24
0.59×
Q3 24
0.62×
Q2 24
0.11×
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
HLMN
HLMN
Operating Cash FlowLast quarter
$8.2M
Free Cash FlowOCF − Capex
$3.4M
$-34.3M
FCF MarginFCF / Revenue
1.2%
-9.3%
Capex IntensityCapex / Revenue
1.8%
4.0%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$22.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
HLMN
HLMN
Q1 26
Q4 25
$8.2M
$30.9M
Q3 25
$26.2M
Q2 25
$-72.9M
$48.7M
Q1 25
$40.3M
$-655.0K
Q4 24
$43.1M
Q3 24
$63.7M
Q2 24
$-39.8M
$64.8M
Free Cash Flow
HCM
HCM
HLMN
HLMN
Q1 26
$-34.3M
Q4 25
$3.4M
$16.1M
Q3 25
$9.1M
Q2 25
$-82.2M
$31.2M
Q1 25
$32.5M
$-21.3M
Q4 24
$22.1M
Q3 24
$39.6M
Q2 24
$-49.9M
$42.5M
FCF Margin
HCM
HCM
HLMN
HLMN
Q1 26
-9.3%
Q4 25
1.2%
4.4%
Q3 25
2.1%
Q2 25
-29.6%
7.7%
Q1 25
10.0%
-5.9%
Q4 24
6.3%
Q3 24
10.1%
Q2 24
-16.3%
11.2%
Capex Intensity
HCM
HCM
HLMN
HLMN
Q1 26
4.0%
Q4 25
1.8%
4.0%
Q3 25
4.0%
Q2 25
3.3%
4.3%
Q1 25
2.4%
5.7%
Q4 24
6.0%
Q3 24
6.1%
Q2 24
3.3%
5.9%
Cash Conversion
HCM
HCM
HLMN
HLMN
Q1 26
Q4 25
4.21×
19.33×
Q3 25
1.13×
Q2 25
-0.16×
3.08×
Q1 25
3.38×
Q4 24
Q3 24
8.57×
Q2 24
-1.54×
5.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons